EP3728313
SAMSETT KRABBAMEINSMEÐFERÐ MEÐ IAP BLOKKA OG AND-PD-1 SAMEIND
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
21.12.2018EP published:
2.8.2023EP application number:
18829861.6
EP translation filed:
26.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
20.12.2038Expiry date:
20.12.2025
Title in English:
COMBINATION ANTI CANCER THERAPY WITH AN IAP ANTAGONIST AND AN ANTI PD-1 MOLECULELanguage of the patent:
English
Timeline
Today
21.12.2018EP application
2.8.2023EP Publication
26.10.2023Translation submitted
15.11.2023Registration published
20.12.2025Expires
Owner
Name:
Debiopharm International S.A.Address:
Forum "après-demain" Chemin Messidor 5-7, 1006 Lausanne, CH
Inventor
Name:
VUAGNIAUX, GrégoireAddress:
1005 Lausanne, CH
Name:
WIEDEMANN, NorbertAddress:
1006 Lausanne, CH
Name:
GAVILLET, BrunoAddress:
01220 Grilly, FR
Name:
SZYLDERGEMAJN ALTMAN, Sergio AdrianAddress:
1162 Saint Prex, CH
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
PCT/IB2017/001595Date:
21.12.2017Country:
WO
Classification
Categories:
C07K 16/28, A61K 45/06, A61P 35/00, A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 15.12.2023
Expires: 20.12.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.12.2024
Expires: 20.12.2025
Payer: Árnason Faktor ehf.